Archive - September 2024
RxPreferred Launches AI-Powered Savings Program for Members
AAM Names John A. Murphy as CEO
Pharma Pulse 9/27/24: Coverage from LogiPharma USA 2024, Payers Looking for Change in Pharmacy Benefits & more
Disposing of Non-Core Assets with Minimal Disruption
What is the Secret Sauce for Top School Graduates to Convert Start-Up Ideas into Sustainable Firms?
FDA Approves Bristol Myers Squibb’s Cobenfy for Schizophrenia
FDA Approves Dupixent as First-Ever Biologic Treatment for Chronic Obstructive Pulmonary Disease
Areas That Will Benefit Most From Increased VC/Fed Funding